Skip to main content
Erschienen in: World Journal of Urology 12/2015

01.12.2015 | Original Article

Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta

verfasst von: Atiqullah Aziz, Michael Gierth, Michael Rink, Marianne Schmid, Felix K. Chun, Roland Dahlem, Florian Roghmann, Rein-Jüri Palisaar, Joachim Noldus, Jörg Ellinger, Stefan C. Müller, Armin Pycha, Thomas Martini, Christian Bolenz, Rudolf Moritz, Edwin Herrmann, Bastian Keck, Bernd Wullich, Roman Mayr, Hans-Martin Fritsche, Maximilian Burger, Patrick J. Bastian, Christian Seitz, Sabine Brookman-May, Evanguelos Xylinas, Shahrokh F. Shariat, Margit Fisch, Matthias May, the PROMETRICS 2011 Research Group

Erschienen in: World Journal of Urology | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Abstract

Radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB) is associated with heterogeneous functional and oncological outcomes. The aim of this study was to generate trifecta and pentafecta criteria to optimize outcome reporting after RC.

Methods

We interviewed 50 experts to consider a virtual group of patients (age ≤ 75 years, ASA score ≤ 3) undergoing RC for a cT2 UCB and a final histology of ≤pT3pN0M0. A ranking was generated for the three and five criteria with the highest sum score. The criteria were applied to the Prospective Multicenter Radical Cystectomy Series 2011. Multivariable binary logistic regression analyses were used to evaluate the impact of clinical and histopathological parameters on meeting the top selected criteria.

Results

The criteria with the highest sum score were negative soft tissue surgical margin, lymph node (LN) dissection of at least 16 LNs, no complications according to Clavien–Dindo grade 3–5 within 90 days after RC, treatment-free time between TUR-BT with detection of muscle-invasive UCB and RC <3 months and the absence of local UCB-recurrence in the pelvis ≤12 months. The first three criteria formed trifecta, and all five criteria pentafecta. A total of 334 patients qualified for final analysis, whereas 35.3 and 29 % met trifecta and pentafecta criteria, respectively. Multivariable analyses showed that the relative probability of meeting trifecta and pentafecta decreases with higher age (3.2 %, p = 0.043 and 3.3 %, p = 0.042) per year, respectively.

Conclusions

Trifecta and pentafecta incorporate essential criteria in terms of outcome reporting and might be considered for the improvement of standardized quality assessment after RC for UCB.
Literatur
1.
Zurück zum Zitat Novotny V, Hakenberg OW, Wiessner D et al (2007) Perioperative complications of radical cystectomy in a contemporary series. Eur Urol 51:397–402CrossRefPubMed Novotny V, Hakenberg OW, Wiessner D et al (2007) Perioperative complications of radical cystectomy in a contemporary series. Eur Urol 51:397–402CrossRefPubMed
2.
Zurück zum Zitat Mayr R, May M, Martini T et al (2012) Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJUI 110:222–227CrossRef Mayr R, May M, Martini T et al (2012) Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJUI 110:222–227CrossRef
3.
Zurück zum Zitat Smaldone MC, Corcoran AT, Hayn M et al (2009) Estimating postoperative mortality and morbidity risk of radical cystectomy with continent diversion using predictor equations. J Urol 182:2619–2624CrossRefPubMed Smaldone MC, Corcoran AT, Hayn M et al (2009) Estimating postoperative mortality and morbidity risk of radical cystectomy with continent diversion using predictor equations. J Urol 182:2619–2624CrossRefPubMed
4.
Zurück zum Zitat Isbarn H, Jeldres C, Zini L et al (2009) A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol 182:70–77CrossRefPubMed Isbarn H, Jeldres C, Zini L et al (2009) A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol 182:70–77CrossRefPubMed
5.
Zurück zum Zitat Aziz A, May M, Burger M et al (2014) Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 66:156–163CrossRefPubMed Aziz A, May M, Burger M et al (2014) Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 66:156–163CrossRefPubMed
6.
Zurück zum Zitat Shariat SF, Karakiewicz PI, Palapattu GS et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176:2414–2422CrossRefPubMed Shariat SF, Karakiewicz PI, Palapattu GS et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176:2414–2422CrossRefPubMed
7.
Zurück zum Zitat Bianco FJ Jr, Scardino PT, Eastham JA (2005) Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 66:83–94CrossRefPubMed Bianco FJ Jr, Scardino PT, Eastham JA (2005) Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 66:83–94CrossRefPubMed
8.
Zurück zum Zitat Hung AJ, Cai J, Simmons MN, Gill IS (2013) “Trifecta” in partial nephrectomy. J Urol 189:36–42CrossRefPubMed Hung AJ, Cai J, Simmons MN, Gill IS (2013) “Trifecta” in partial nephrectomy. J Urol 189:36–42CrossRefPubMed
9.
Zurück zum Zitat Patel VR, Sivaraman A, Coelho RF et al (2011) Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol 59:702–707CrossRefPubMed Patel VR, Sivaraman A, Coelho RF et al (2011) Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol 59:702–707CrossRefPubMed
10.
Zurück zum Zitat Svatek RS, Fisher MB, Matin SF et al (2010) Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol 183:929–934CrossRefPubMed Svatek RS, Fisher MB, Matin SF et al (2010) Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol 183:929–934CrossRefPubMed
11.
Zurück zum Zitat Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity after radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174CrossRefPubMed Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity after radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174CrossRefPubMed
12.
Zurück zum Zitat Witjes JA, Compérat E, Cowan NC et al (2014) EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65(4):778–792CrossRefPubMed Witjes JA, Compérat E, Cowan NC et al (2014) EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65(4):778–792CrossRefPubMed
13.
Zurück zum Zitat Rink M, Fajkovic H, Cha EK et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61:854–855CrossRefPubMed Rink M, Fajkovic H, Cha EK et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61:854–855CrossRefPubMed
14.
Zurück zum Zitat Novotny V, Froehner M, May M et al (2015) Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder. World J Urol [Epub ahead of print] Novotny V, Froehner M, May M et al (2015) Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder. World J Urol [Epub ahead of print]
15.
Zurück zum Zitat Gakis G, Ngamsri T, Rausch S et al (2015) Fluorescence-guided bladder tumour resection: impact on survival after radical cysrectomy. World J Urol [Epub ahead of print] Gakis G, Ngamsri T, Rausch S et al (2015) Fluorescence-guided bladder tumour resection: impact on survival after radical cysrectomy. World J Urol [Epub ahead of print]
16.
Zurück zum Zitat Froehner M, Novotny V, Wirth MP et al (2014) External validation of a model to predict locoregional failure after radical cystectomy. Cancer 120(22):3584CrossRefPubMed Froehner M, Novotny V, Wirth MP et al (2014) External validation of a model to predict locoregional failure after radical cystectomy. Cancer 120(22):3584CrossRefPubMed
17.
Zurück zum Zitat Christodouleas JP, Baumann BC, He J et al (2014) Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. Cancer 120:1272–1280CrossRefPubMed Christodouleas JP, Baumann BC, He J et al (2014) Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. Cancer 120:1272–1280CrossRefPubMed
18.
Zurück zum Zitat Roth B, Wissmeyer MP, Zehnder P et al (2010) A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 57:205–211CrossRefPubMed Roth B, Wissmeyer MP, Zehnder P et al (2010) A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 57:205–211CrossRefPubMed
19.
Zurück zum Zitat Zehnder P, Studer UE, Skinner EC et al (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186:1261–1268CrossRefPubMed Zehnder P, Studer UE, Skinner EC et al (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186:1261–1268CrossRefPubMed
20.
Zurück zum Zitat Leissner J, Hohenfellner R, Thüroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional call carcinoma of the urinary bladder. BJU 85:817–823CrossRef Leissner J, Hohenfellner R, Thüroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional call carcinoma of the urinary bladder. BJU 85:817–823CrossRef
21.
Zurück zum Zitat Sobin LH, Wittekind Ch (1997) TNM Classification of Malignant Tumours, 5th edn. Wiley-Liss, New York Sobin LH, Wittekind Ch (1997) TNM Classification of Malignant Tumours, 5th edn. Wiley-Liss, New York
22.
Zurück zum Zitat May M, Herrmann E, Bolenz C et al (2011) Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol 18:2018–2025CrossRefPubMed May M, Herrmann E, Bolenz C et al (2011) Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol 18:2018–2025CrossRefPubMed
23.
Zurück zum Zitat Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 115:988–996PubMedCentralCrossRefPubMed Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 115:988–996PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Burger M, Mulders P, Witjes W (2012) Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 61:1070–1071CrossRefPubMed Burger M, Mulders P, Witjes W (2012) Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 61:1070–1071CrossRefPubMed
25.
Zurück zum Zitat Hedgebeth RC, Gilbert SM, He C et al (2010) Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urology 76:671–675CrossRef Hedgebeth RC, Gilbert SM, He C et al (2010) Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urology 76:671–675CrossRef
26.
Zurück zum Zitat Takada N, Abe T, Shinohara N et al (2012) Perioperative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan. BJUI 110:756–764CrossRef Takada N, Abe T, Shinohara N et al (2012) Perioperative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan. BJUI 110:756–764CrossRef
27.
Zurück zum Zitat Schmid M, Rink M, Traumann M et al (2015) Evidence from the `PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)` Study: How are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Ann Surg Oncol 22:1032–1042CrossRefPubMed Schmid M, Rink M, Traumann M et al (2015) Evidence from the `PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)` Study: How are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Ann Surg Oncol 22:1032–1042CrossRefPubMed
28.
Zurück zum Zitat Novara G, Catto JW, Wilson T et al (2015) Systemic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol 67(3):376–401CrossRefPubMed Novara G, Catto JW, Wilson T et al (2015) Systemic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol 67(3):376–401CrossRefPubMed
29.
Zurück zum Zitat Colombo R, Pellucchi F, Moschini M et al (2015) Fifteen-year single-center experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients. World J Urol. doi:10.1007/s00345-015-14 Colombo R, Pellucchi F, Moschini M et al (2015) Fifteen-year single-center experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients. World J Urol. doi:10.​1007/​s00345-015-14
Metadaten
Titel
Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta
verfasst von
Atiqullah Aziz
Michael Gierth
Michael Rink
Marianne Schmid
Felix K. Chun
Roland Dahlem
Florian Roghmann
Rein-Jüri Palisaar
Joachim Noldus
Jörg Ellinger
Stefan C. Müller
Armin Pycha
Thomas Martini
Christian Bolenz
Rudolf Moritz
Edwin Herrmann
Bastian Keck
Bernd Wullich
Roman Mayr
Hans-Martin Fritsche
Maximilian Burger
Patrick J. Bastian
Christian Seitz
Sabine Brookman-May
Evanguelos Xylinas
Shahrokh F. Shariat
Margit Fisch
Matthias May
the PROMETRICS 2011 Research Group
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1572-x

Weitere Artikel der Ausgabe 12/2015

World Journal of Urology 12/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.